SCHEMBL3429977

SCHEMBL3429977

CN(CCN)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13745040 0.91 KDM4E (0.32)
SCHEMBL24951938 0.90 HRH4 (0.39)
SCHEMBL3186493 0.87 HRH3 (0.42)
Hydrochloric Acid SCHEMBL6897821 0.85 HRH4 (0.41)
Hydrochloric Acid SCHEMBL27567168 0.85 HRH4 (0.41)
SCHEMBL6967400 0.84
SCHEMBL8851861 0.84 NOS3 (0.36)
SCHEMBL18248982 0.84 PIK3CD (0.53)
SCHEMBL8851859 0.84
SCHEMBL6961851 0.82 CHRM2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4463452-B1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC (US) 2025-07-30 EP disclosed
US-12344600-B2 c-Myc mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-07-01 US disclosed
US-20250109128-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2025-04-03 US disclosed
US-20200331910-A1 Mammalian and Bacterial Nitric Oxide Synthase Inhibitors UNIV NORTHWESTERN (US) 2020-10-22 US disclosed
US-10759791-B2 Mammalian and bacterial nitric oxide synthase inhibitors NORTHWESTERN UNIVERSITY (US) 2020-09-01 US disclosed
US-9951014-B2 Mammalian and bacterial nitric oxide synthase inhibitors NORTHWESTERN UNIVERSITY (US) 2018-04-24 US disclosed
US-20160122302-A1 Mammalian and Bacterial Nitric Oxide Synthase Inhibitors NORTHWESTERN UNIVERSITY 2016-05-05 US disclosed
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
EP-2262789-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
EP-1578409-B1 USE OF ADENOSINE A2A RECEPTOR ANTAGONISTS FOR TREATMENT OR PREVENTION OF EXTRA-PYRAMIDAL SYNDROME SCHERING CORP (US) 2010-12-08 EP disclosed
EP-0870765-B1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARM CO LTD (JP) 2003-11-19 EP disclosed
CN-1063442-C Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds ZERIA PHARM CO LTD (JP) 2001-03-21 CN disclosed
US-5981557-A HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-11-09 US disclosed
EP-0870765-A1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARMACEUTICAL CO., LTD. (JP) 1998-10-14 EP disclosed
CN-1184471-A Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds ZERIA PHARM CO LTD (JP) 1998-06-10 CN disclosed
CN-1021441-C PROCESS FOR PREPARATION OF NEW BENZAMIDES ILE DE FRANCE (FR) 1993-06-30 CN disclosed
US-5010108-A Treatment of gastrointestinal disorders POLI INDUSTRIA CHIMICA S.P.A. (IT) 1991-04-23 US disclosed
EP-0411494-A2 Ergoline derivatives having dopaminergic activity POLI INDUSTRIA CHIMICA S.p.A. (IT) 1991-02-06 EP disclosed
EP-0333073-A2 N-cycloalkylaminoethylbenzamide derivatives, their synthesis and pharmaceutical preparations POLI INDUSTRIA CHIMICA S.p.A. (IT) 1989-09-20 EP disclosed
CN-86105682-A Novel benzamides, process for their preparation and their use in therapy 1987-02-04 CN disclosed